Skip to main content

Branded

  • FDA approves Lilly's plaque psoriasis treatment Taltz

    SILVER SPRING, Md. — The Food and Drug Administration announced Tuesday that it had approved Eli Lilly and Co.’s new drug Taltz (ixekizumab). The drug is indicated to treat moderate to severe plaque psoriasis in adults. 
     

  • Aprecia announces availability of 3D-printed drug Spritam

    BLUE ASH, Ohio — Aprecia Pharmaceuticals announced the U.S. availability of its Spritam (levetiracetam) tablets on Tuesday. The epilepsy medication is the first tablet made using the company’s ZipDose 3D printing technology to be approved by the Food and Drug Administration. It is designed to dissolve with a sip of liquid, easing the process of taking medication for patients with difficulty swallowing, the company said. 

  • Fitch Ratings: Anthem v. Express Scripts suit could shake up PBM industry

    NEW YORK - The outcome of a dispute between Anthem and Express Scripts, underscored by a lawsuit announced Monday, could have far-reaching effects on the evolving pharmacy benefits management industry and implications for Express Scripts' independent business model, Fitch Ratings reported Tuesday. 
     

  • JAMA studies suggest need for increase monitoring of medications, supplements

  • Study: 1-in-6 older adults could be at risk for adverse drug interactions

    CHICAGO — A new study published in JAMA Internal Medicine is taking a look at the potentially dangerous interactions older Americans court when taking several medications — both prescription and OTC, as well as supplements — at once. The study looked at data from the 2005-2006 and 2010-2011, comparing the two on instances of polypharmacy (concurrent use of more than five prescription medications), as well as instances of taking more than five prescription and non-prescription medicine, including OTC medication and supplements. 

  • GSK in search of CEO following retirement announcement

    LONDON - Andrew Witty, GlaxoSmithKline CEO, will retire from GSK in early 2017, the company announced Thursday. 
     
    GSK has implemented a formal search for a successor, who will assume the role March 31, 2017, and will consider internal and external candidates for the role.
     

  • Walgreens tracks biggest weekly flu gains in Kentucky, Deleware and South Dakota

    DEERFIELD, Ill. - The Walgreens Flu Index on Thursday indicated that most of the nation is contending with relatively high levels of flu incidence for the week of March 13, with Kentucky, Mississippi and Tennessee topping the charts in states with flu activity. Among states, the biggest flu incidence gainers for the week were Kentucky, Deleware and South Dakota. 
     
    The top 10 markets with flu activity for the week of March 13 were: 
     
    1. El Paso, Texas (Las Cruces, N.M.);

  • Senate passes Ensuring Patient Access and Effective Drug Enforcement Act

    WASHINGTON — The Senate this week unanimously passed the Ensuring Patient Access and Effective Drug Enforcement Act to help ensure that prescription drugs land in the hands of patients and not those who would abuse them.  
     
X
This ad will auto-close in 10 seconds